Future directions for resuscitation research. IV. Innovative advanced life support pharmacology

Resuscitation

Volumn 33, Issue 2, 1996, Pages 163-177

  Brown, Charles ^b   Wiklund, Lars ^b   Bar Joseph, Gad ^b   Miller, Brian ^b   Bircher, Nicholas ^b   Paradis, Norman ^b   Menegazzi, James ^b   Von Planta, Martin ^b   Kramer, George C ^b   Gisvold, Sven Erik ^b   Safar, Peter ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b NONE

Author keywords

Adrenergic agonists; Anti arrhythmia agents; Buffers; Cardiopulmonary resuscitation; Clinical trials; Defibrillation; Electric countershock; Electrocardiography; Intraosseous medication; Ventricular fibrillation

Indexed keywords

21 [4 [2,6 BIS(1 PYRROLIDINYL) 4 PYRIMIDINYL] 1 PIPERAZINYL]PREGNA 1,4,9(11) TRIENE 3,20 DIONE; ADRENALIN; ADRENERGIC RECEPTOR STIMULATING AGENT; AMINOPHYLLINE; AMIODARONE; ANTIARRHYTHMIC AGENT; BICARBONATE; BRETYLIUM; BUFFER; CARBICARB; HYPERTENSIVE FACTOR; HYPERTONIC SOLUTION; IMIDAZOLINE DERIVATIVE; LIDOCAINE; MAGNESIUM SULFATE; METHOXAMINE; NORADRENALIN; PHENYLEPHRINE; PROCAINE; PROPRANOLOL; TRIBONATE; TROMETAMOL; UNCLASSIFIED DRUG;

BLOOD PRESSURE; CARDIOVERSION; CIRCULATION; CLINICAL TRIAL; DOSE RESPONSE; DRUG EFFECT; DRUG MECHANISM; ELECTROCARDIOGRAM; HEART ARREST; HEART VENTRICLE FIBRILLATION; HUMAN; INTRAARTERIAL DRUG ADMINISTRATION; INTRACARDIAC DRUG ADMINISTRATION; INTRAOSSEOUS DRUG ADMINISTRATION; INTRATRACHEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MEDICAL RESEARCH; META ANALYSIS; NONHUMAN; PATIENT MONITORING; POWER SPECTRUM; PRIORITY JOURNAL; RESUSCITATION; REVIEW;

EID: 17344382792     PISSN: 03009572     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0300-9572(96)01017-9     Document Type: Article

References (159)

1. [1] Crile G, Dolley DH. An experimental research into the resuscitation of dogs killed by anesthetics and asphyxia. J Exp Med 1906; 8: 713-725.
2. [2] Redding JS, Pearson JW. Resuscitation from asphyxia. JAMA 1962; 182: 163-166.
3. [3] Redding J, Pearson JW. Resuscitation from ventricular fibrillation. JAMA 1968; 203: 255-260.
4. [4] Pearson JW, Redding JS. The role of epinephrine in cardiac resuscitation. Anesth Analg 1963; 5: 599-606.
5. [5] Pearson JW, Redding JS. Epinephrine in cardiac resuscitation. Am Heart J 1963; 66: 210-214.
6. [6] Monroe RG, French G. Ventricular pressure-volume relationships and oxygen consumption in fibrillation and arrest. Circ Res 1960; 8: 260-266.
7. [7] Hashimoto K, Shigei T, Imai S et al. Oxygen consumption and coronary vascular tone in the isolated fibrillating dog heart. Am J Physiol 1960; 198: 965-970.
8. [8] Downey JM, Chagrasulis RW, Hemphill V. Quantitative study of intramyocardial compression in the fibrillating heart. Am J Physiol 1979; 237: H191-H196.
9. [9] Gibbs CL, Papdoyannis DE, Drake AJ et al. Oxygen consumption of the nonworking and potassium chloride-arrest dog heart. Circ Res 1980; 47: 408-417.
10. [10] Paradis NA, Martin GB, Rivers EP et al. Coronary perfusion pressure and return of spontaneous circulation in human cardiopulmonary resuscitation. JAMA 1990; 263: 1106-1113.
11. [11] Sundt TM, Sharbrough FW, Piepgras DG et al. Correlation of cerebral blood flow and electroencephalographic changes during carotid endarterectomy with results of surgery and hemodynamics of cerebral ischemia. Mayo Clin Proc 1981; 56: 533-543.
12. [12] Branston NM, Strong AJ, Symon L. Extracellular potassium activity, evoked potential and tissue blood flow. J Neurol Sci 1977; 32: 305-321.
13. [13] Niemann JT. Differences in cerebral and myocardial perfusion during closed-chest resuscitation. Ann Emerg Med 1984; 13: 849-853.
14. [14] Ditchey RV, Winkler JV, Rhodes CA. Relative lack of coronary blood flow during closed-chest resuscitation in dogs. Circulation 1982; 66: 297-302.
15. [15] Lee SK, Vaagenes P, Safar P et al. Effect of cardiac arrest time on cortical cerebral blood flow during subsequent standard external cardiopulmonary resuscitation in rabbits. Resuscitation 1989; 17: 105-117.
16. [16] Lee SK, Vaagenes P, Safar P et al. Effect of cardiac arrest time on the cortical cerebral blood flow generated by subsequent standard external CPR in rabbits. Ann Emerg Med 1984; 13: 385 (abstract).
17. [17] Sterz F, Leonov Y, Safar P et al. Hypertension with or without hemodilution after cardiac arrest in dogs. Stroke 1990; 21: 1178-1184.
18. [18] Safar P. Prevention and therapy of postresuscitation neurologic dysfunction and injury. In: Paradis NA, Halperin HR, Nowak RM, editors. Cardiac arrest. The science and practice of resuscitation medicine, Ch. 49. Philadelphia: Williams and Wilkins, 1996: 859-887.
19. [19] Klocke FJ, Ellis AK. Control of coronary blood flow. Ann Rev Med 1980; 31: 489-508.
20. [20] Ditchey RV, Lindenfeld J. Potential adverse effects of volume loading on perfusion of vital organs during closed-chest resuscitation. Circulation 1984; 69: 181-189.
21. [21] Gentile NT, Martin GB, Appleton TJ et al. Effects of arterial and venous volume infusion on coronary perfusion pressure during canine CPR. Resuscitation 1991; 22: 55-63.
22. [22] Michael JR, Guerci AD, Koehler RC et al. Mechanisms by which epinephrine augments cerebral and myocardial perfusion during cardiopulmonary resuscitation in dogs. Circulation 1984; 69: 822-835.
23. [23] Brown CG, Werman HA. Adrenergic agonists during cardiopulmonary resuscitation. Resuscitation 1990; 19: 1-16.
24. [24] Ornalo JP. Use of adrenergic agonists during CPR in adults (review). Ann Emerg Med 1993; 22: 411-416.
25. [25] Olson DW, Thakur R, Stueven HA et al. Randomized study of epinephrine versus methoxamine in prehospital ventricular fibrillation. Ann Emerg Med 1989; 18: 250-253.
26. [26] Turner LM, Parsons M, Luetkemeyer RC et al. A comparison of epinephrine and methoxamine for resuscitation from electromechanical dissociation in human beings. Ann Emerg Med 1988; 17: 443-449.
27. [27] Lindner KH, Ahnefeld FW, Grunert A. Epinephrine versus norepinephrine in prehospital ventricular fibrillation. Am J Cardiol 1991; 67: 427-428.
28. [28] Kosnik JW, Jackson RE, Keats S et al. Dose-related response of centrally administered epinephrine on the change in aortic diastolic pressure during closed-chest massage in dogs. Ann Emerg Med 1985; 14: 204-208.
29. [29] Brown CG, Werman HA, Davis EA et al. The effects of graded doses of epinephrine on regional myocardial blood flow during cardiopulmonary resuscitation in swine. Circulation 1987; 75: 491-497.
30. [30] Lindner KH, Ahnefeld FW, Bowdler IM. Comparison of different doses of epinephrine on myocardial perfusion and resuscitation success during cardiopulmonary resuscitation in a pig model. Am J Emerg Med 1991; 9: 27-31.
31. [31] Gonzalez ER, Ornato JP, Garnett AR et al. Dose-dependent vasopressor response to epinephrine during CPR in human beings. Ann Emerg Med 1989; 18: 920-926.
32. [32] Paradis NA, Martin GB, Rosenberg J et al. The effect of standard-and high-dose epinephrine on coronary perfusion pressure during prolonged cardiopulmonary resuscitation. JAMA 1991; 265: 1139-1144.
33. [33] Goetting MG, Paradis NA. High-dose epinephrine improves outcome from pediatric cardiac arrest. Ann Emerg Med 1991; 20: 22-26.
34. [34] Lindner KH, Ahnefeld FW, Prengel AW. Comparison of standard and high-dose adrenaline in the resuscitation of asystole and electromechanical dissociation. Acta Anaesthesiol Scand 1991; 35: 253-256.
35. [35] Callaham M, Madsen CD, Barton CW, Saunders CE, Pointer J. A randomized clinical trial of high-dose epinephrine and norepinephrine vs standard-dose epinephrine in prehospital cardiac arrest. JAMA 1992; 268: 2667-2672.
36. [36] Abramson NS, Safar P, Sutton-Tyrrell K et al. Randomized clinical trial of escalating doses of high-dose epinephrine during cardiac resuscitation. Ann Emerg Med 1995; 25: 130 (abstract).
37. [37] Stiell IG, Hebert PC, Weitzman BN et al. High-dose epinephrine in adult cardiac arrest. N Engl J Med 1992; 327: 1045-1050.
38. [38] Brown CG, Martin D, Pepe P et al. A comparison of standard-dose and high-dose epinephrine in cardiac arrest outside the hospital. N Engl J Med 1992; 327: 1051-1055.
39. [39] Ditchey RV, Lindenfeld J. Failure of epinephrine to improve the balance between myocardial oxygen supply and demand during closed-chest resuscitation in dogs. Circulation 1988; 78: 382-389.
40. [40] Klocke FJ, Kaiser GA, Ross J et al. Mechanism of increase of myocardial oxygen uptake produced by catecholamines. Am J Physiol 1965; 209: 913-918.
41. [41] Tang W, Weil MH, Gazmuri RJ et al. Pulmonary ventilation/ perfusion defects induced by epinephrine during cardiopulmonary resuscitation. Circulation 1991; 84: 2101-2107.
42. [42] Todd GL, Baroldi G, Pieper GM et al. Experimental catecholamine-induced myocardial necrosis. I. Morphology, quantification and regional distribution of acute contract band lesion. J Mol Cell Cardiol 1985; 17: 317-338.
43. [43] Rona G. Catecholamine cardiotoxicity. J Mol Cell Cardiol 1985; 17: 291-306.
44. [44] Brown CG, Little C, Swart G et al. The effect of St-91 on hemodynamics during CPR. Ann Emerg Med 1994; 23: 923-924 (abstract).
45. [45] Little CM, Brown CG. Angiotensin II improves myocardial blood flow in cardiac arrest. Resuscitation 1993; 26: 203-210.
46. [46] Woodhouse SP, Case C, Cox S et al. Trial of large dose adrenaline versus placebo in cardiac arrest. Resuscitation 1994; 26: 89 (abstract).
47. [47] Little RA, Frayn KN, Randall PE et al. Plasma catecholamines in patients with acute myocardial infarction and in cardiac arrest. Q J Med 1985; 54: 133-140.
48. [48] Foley PJ, Tacker WA, Wortsman J et al. Plasma catecholamine and serum cortisol responses to experimental cardiac arrest in dogs. Am J Physiol 1987; 253: E283-E289.
49. [49] Kern KB, Elchisak MA, Sanders AB et al. Plasma catecholamines and resuscitation from prolonged cardiac arrest. Crit Care Med 1989; 17: 786-791.
50. [50] Schoffstall JM, Spivey WH, Davidheiser S et al. Endogenous and exogenous plasma catecholamine levels in cardiac arrest in swine. Resuscitation 1990; 19: 241-251.
51. [51] Paradis NA, Rivers EP, Martin GB et al. The change in arterial epinephrine levels after standard and high dose epinephrine during CPR in humans. Crit Care Med 1990; 18: S221 (abstract).
52. [52] Wortsman J, Nowak RM, Martin GB et al. Plasma epinephrine levels in resuscitation with cardiopulmonary bypass. Crit Care Med 1990; 18: 1134-1137.
53. [53] Shen WK, Kurachi Y. Mechanisms of adenosine-mediated actions on cellular and clinical cardiac electrophysiology. Mayo Clin Proc 1995; 70: 274-291.
54. [54] Kern K, Garewal H, Sanders A et al. Depletion of myocardial adenosine triphosphate during prolonged untreated ventricular fibrillation: effect on defibrillation success. Resuscitation 1990; 20: 221-229.
55. [55] Viskin S. Ammophyllin for bradyasystolic cardiac arrest refractory to atropine and epinephrine. Ann Intern Med 1993; 118: 279-281.
56. [56] Negovsky VA, Gurvitch AM, Zolotokrylina ES. Postresuscitation disease. Amsterdam: Elsevier, 1983.
57. [57] Kirimli B, Kampschulte S, Safar P. Resuscitation from cardiac arrest due to exsanguination. Surg Gynecol Obstet 1969; 129: 89-97.
58. [58] Vaagenes P, Cantadore R, Safar P et al. Amelioration of brain damage by lidoflazine after prolonged ventricular fibrillation cardiac arrest in dogs. Crit Care Med 1984; 12: 846-855.
59. [59] Ebmeyer U, Safar P, Katz L et al. Intracarotid-intraaortic (IA) epinephrine injection for CPR in cardiac arrest (CA) of rats. Resuscitation 1992; 24: 190 (abstract).
60. [60] Manning JE, Murphy CA, Batson DN et al. Aortic arch versus central venous epinephrine during CPR. Ann Emerg Med 1993; 22: 703-708.
61. [61] American Heart Association Committee on Emergency Cardiac Care. Guidelines for cardiopulmonary resuscitation and emergency cardiac care. Adult advanced cardiac life support. JAMA 1992; 268: 2199-2241.
62. [62] Bar-Joseph G, Ben-Haim S, Castel T et al. Response to repeated, equal, high doses of epinephrine during cardiopulmonary resuscitation in dogs. Crit Care Med 1993; 21: S271 (abstract).
63. [63] Miller D, Craddock L, Hoffenberg S et al. Pilot study of i.v. magnesium sulfate in refractory in-hospital cardiac arrest: safety data and recommendations for future studies. Resuscitation 1995; 30: 3-15.
64. [64] Brown C, Griffith R, Miller B et al. The effect of intravenous magnesium administration on aortic, right atrial, and coronary perfusion pressures during CPR in swine. Resuscitation 1993; 26: 3-12.
65. [65] Tacker WA, Niebauer MJ, Babbs CF et al. The effect of newer antiarrhythmic drugs on defibrillation threshold. Crit Care Med 1980; 8: 177-180.
66. [66] Babbs CF, Yim GKW, Whistler SJ et al. Elevation of ventricular defibrillation threshold in dogs by antiarrhythmic drugs. Am Heart J 1979; 98: 345-350.
67. [67] Echt DS, Black JN, Barbey JT et al. Evaluation of antiarrhythmic drugs on defibrillation energy requirements in dogs. Circulation 1989; 79(5): 1106-1117.
68. [68] Dorian P, Fain ES, Davy J et al. Lidocaine causes a reversible, concentration-dependent increase in defibrillation energy requirements. JACC 1986; 9: 327-332.
69. [69] Chow MSS, Ronfeldt RA, Hamilton RA et al. Effect of external CPR on lidocaine pharmacokinetics in dogs. J Pharmacol Exp Ther 1983; 244: 531-537.
70. [70] Kerber RE, Pandian NG, Jensen SR et al. Effect of lidocaine and bretylium on energy requirements for transthoracic defibrillation: experimental studies. JACC 1986; 7: 397-405.
71. [71] Dorian P, Fain ES, Davy J et al. Effect of quinidine and bretylium on defibrillation energy requirements. Am Heart J 1986; 112(1): 19-24.
72. [72] Koo CC, Allen JD, Pantridge JF. Lack of effect of bretylium tosylate on electrical ventricular defibrillation in a controlled study. Cardio Res 1984; 18: 762-767.
73. [73] Chow MSS, Kluger J, Lawrence R et al. The effect of lidocaine and bretylium on the defibrillation threshold during cardiac arrest and cardiopulmonary resuscitation. Proc Soc Exp Bio Med 1986; 182: 63-67.
74. [74] Euler DE, Zeman TW, Wallock ME et al. Deleterious effects of bretylium on hemodynamic recovery from ventricular fibrillation. Am Heart J 1986; 112: 25-31.
75. [75] Spivey WH, Abramson NS, Safar P et al. Correlation of blood pressure with mortality and neurologic recovery in comatose postresuscitation patients. Ann Emerg Med 1991; 20: 453-454 (abstract).
76. [76] Haynes RE, Chinn TL, Copass MK et al. Comparison of bretylium tosylate and lidocaine in management of out of hospital ventricular fibrillation: a randomized clinical trial. Am J Cardiol 1981; 48: 353-356.
77. [77] Olson DW, Thompson BM, Darin JC et al. A randomized comparison study of bretylium tosylate and lidocaine in resuscitation of patients from out-of-hospital ventricular fibrillation in a paramedic system. Ann Emerg Med 1984; 13(9): 807-810.
78. [78] Weaver WD, Fahrenbruck CE, Johnson DD et al. Effect of epinephrine and lidocaine therapy on outcome after cardiac arrest due to ventricular fibrillation. Circulation 1990; 82: 2027-2034.
79. [79] Williams ML. Intravenous amiodarone during prolonged resuscitation from cardiac arrest. Ann Int Med 1989; 110: 839-842.
80. [80] Sellevold OFM, Berg EM, Levang OW. Procaine is effective for minimizing postischemic ventricular fibrillation in cardiac surgery. Anesth Analg 1995; 81: 932-938.
81. [81] Hargarten KM, Stueven HA, Waite EM et al. Prehospital experience with defibrillation of coarse ventricular fibrillation: a ten year review. Ann Emerg Med 1990; 19(2): 157-162.
82. [82] Stewart AJ, Allen JD, Adgey AAJ. Frequency analysis of ventricular fibrillation and resuscitation success. Q J Med 1992; 85: 761-769.
83. [83] Brown CG, Dzwonczyk R, Werman HA et al. Estimating the duration of ventricular fibrillation. Ann Emerg Med 1989; 18: 1181-1185.
84. [84] Menegazzi JJ, Watanabe S, Klain M et al. ECG spectrum analysis predicts return of spontaneous circulation following prolonged ventricular fibrillation. Prehosp Disaster Med 1993; 8(2): S61 (abstract).
85. [85] Menegazzi J, Seaberg D, Yealy D et al. Combined pharmacotherapy with delayed countershock versus standard advanced cardiac life support following prolonged ventricular fibrillation. Acad Emerg Med 1994; 1(2): A19 (abstract).
86. [86] Seaberg D, Menegazzi J, Check B et al. Use of cardiocerebral-protective drug cocktail prior to countershock following prolonged ventricular fibrillation. Prehosp Disaster Med 1994; 9(3): S52 (abstract).
87. [87] Menegazzi J, Davis E, Yealy D et al. An experimental algorithm vs standard ACLS in a swine model of out-of-hospital cardiac arrest. Ann Emerg Med 1993; 22: 235-239.
88. [88] Niemann JT, Cairns CB, Sharma J et al. Treatment of prolonged ventricular fibrillation: immediate countershock versus high-dose epinephrine and CPR preceding countershock. Circulation 1992; 85(1): 281-287.
89. [89] Yakaitis RW, Ewy GA, Otto CW et al. Influence of time and therapy on ventricular fibrillation in dogs. Crit Care Med 1980; 8: 157-163.
90. [90] Niemann JT, Cairns CB, Sharma J et al. Treatment of prolonged ventricular fibrillation: immediate countershock versus high-dose epinephrine and CPR preceding countershock. Circulation 1992; 85: 281-287.
91. [91] Menegazzi JJ, Davis EA, Yealy DM et al. An experimental algorithm versus standard ACLS in a swine model of out-of-hospital cardiac arrest. Ann Emerg Med 1993; 22: 235-239.
92. [92] Brown CG, Griffith RF, Van Ligten P et al. Median frequency - a new parameter for predicting defibrillation success rate. Ann Emerg Med 1991; 20: 787-789.
93. [93] Brown CG, Dzwonczyk R. Signal analysis of the human ECG during ventricular fibrillation (VF)-frequency and amplitude parameters as predictors of successful countershock. Ann Emerg Med 1996; 27: 184-188.
94. [94] Weaver WD, Cobb LA, Dennis D et al. Amplitude of ventricular fibrillation waveform and outcome after cardiac arrest. Ann Intern Med 1985; 102: 53-55.
95. [95] Stults KR, Brown DD, Kerber RE. Ventricular fibrillation amplitude predicts ability to defibrillate. Am J Emerg Med 1986; 4: 423.
96. [96] von Planta I, Wagner O, von Planta M et al. Determinants of survival after rodent cardiac arrest: implications for therapy with adrenergic agents. Int J Cardiol 1993; 38: 235-245.
97. [97] Rubertsson S, Grenvik A, Wiklund L. Blood flow and perfusion pressure during open-chest versus closed-chest cardiopulmonary resuscitation in pigs. Crit Care Med 1995; 23: 715-725.
98. [98] Eleff SM, Schleien CL, Koehler RC et al. Brain bioenergetics during cardiopulmonary resuscitation in dogs. Anesthesiology 1992; 76: 77-84.
99. [99] Wiklund L, Jorfeldt L, Stjernstrom H et al. Gas exchanged as monitored in mixed venous and arterial blood during experimental cardiopulmonary resuscitation. Acta Anaesthesiol Scand 1992; 36: 427-435.
100. [100] Capparelli EV, Chow MSS, Kluger J et al. Differences in systemic and myocardial blood acid base status during experimental cardiopulmonary resuscitation. Acta Anaesthesiol Scand 1992; 36: 427-435.
101. [101] Gazmuri RJ, von Planta M, Weil MH et al. Cardiac effects of carbon dioxide consuming and carbon dioxide-generating buffers during cardiopulmonary resuscitation. J Am Coll Cardiol 1990; 15: 482-490.
102. [102] Effron MB, Guarnieri T, Fredriksen JW et al. Effect of tris (hydroxymethyl) aminomethane on ischemic myocardium. Am J Physiol 1978; 235(2): H167-H174.
103. [103] Grundler W, Weil MH, Rackow EC. Arteriovenous carbon dioxide and pH gradients during cardiac arrest. Circulation 1986; 74: 1071-1074.
104. [104] Weil MH, Rackow EC, Trevino R et al. Differences in acid-base state between venous and arterial blood during cardiopulmonary resuscitation. N Engl J Med 1986; 315: 153-156.
105. [105] Kette F, Weil MH, von Planta M et al. Buffer agents do not reverse intramyocardial acidosis during cardiac resuscitation. Circulation 1990; 81: 1660-1666.
106. [106] von Planta M, Gudipati C, Weil MH et al. Effects of tromethamine and sodium bicarbonate buffers during cardiac resuscitation. J Clin Pharmacol 1988; 28: 594-599.
107. [107] Sanders AB, Otto CW, Kern KB et al. Acid-base balance in a canine model of cardiac arrest. Ann Emerg Med 1988; 17: 667-671.
108. [108] Adrogue HJ, Rashad MN, Gorin AB et al. Assessing acid-base status in circulatory failure. Differences between arterial and central venous blood. N Engl J Med 1989; 320: 1312-1316.
109. [109] Bar-Joseph G, Ben-Haim S, Castel T et al. Improved resuscitability with sodium bicarbonate and Carbicarb after 10 minutes ventricular fibrillation in dogs. Crit Care Med 1993; 21: S271 (abstract).
110. [110] Berenyi KJ, Wolk M, Killip T. Cerebrospinal fluid acidosis complicating therapy of experimental cardiopulmonary arrest. Circulation 1975; 52: 319-324.
111. [111] Wiklund L, Soderberg D, Henneberg S et al. Kinetics of carbon dioxide during cardiopulmonary resuscitation. Crit Care Med 1986; 14: 1015-1022.
112. 31P NMR study. Ann Emerg Med 1989; 18: 341-347.
113. [113] Roberts D, Landolfo K, Light RB et al. Early predictors of mortality for hospitalized patients suffering cardiopulmonary arrest. Chest 1990; 97: 413-419.
114. [114] Weil MH, Ruiz CE, Sybil M et al. Acid-base determinants of survival after cardiopulmonary resuscitation. Crit Care Med 1985; 13: 888-892.
115. [115] Aufderheide TP, Martin DR, Olson DW et al. Prehospital bicarbonate use in cardiac arrest. A 3-year experience. Am J Emerg Med 1992; 10: 4-7.
116. [116] Kirimli B, Harris LC, Safar P. Evaluation of sodium bicarbonate and epinephrine in cardiopulmonary resuscitation. Anesth Analg 1969; 48: 649-658.
117. [117] Sanders AB, Kern KB, Fonken S et al. The role of bicarbonate and fluid loading in improving resuscitation from prolonged cardiac arrest with rapid manual chest compression CPR. Ann Emerg Med 1990; 19: 1-7.
118. [118] Bircher NG. Sodium bicarbonate improves cardiac resuscitability, 24 hour survival and neurological outcome after ten minutes of cardiac arrest in dogs. Anesthesiology 1991; 75: A246 (abstract).
119. [119] Vukmir RB, Bircher NG, Radovsky A et al. Sodium bicarbonate may improve outcome in dogs with brief or prolonged cardiac arrest. Crit Care Med 1995; 23: 515-522.
120. [120] Wiklund L, Ronquist G, Stjernstrom H et al. Effects of alkaline buffer administration on survival and myocardial energy metabolism in pigs subjected to ventricular fibrillation and closed-chest CPR. Acta Anaesthesiol Scand 1990; 34: 430-439.
121. [121] Guerci AD, Chandra N, Johnson E et al. Failure of sodium bicarbonate to improve resuscitation from ventricular fibrillation in dogs. Circulation 1986; 74 (Suppl IV): 75-79.
122. [122] Dybvik T, Strand T, Steen PA. Buffer therapy during out-of-hospital cardiopulmonary resuscitation. Resuscitation 1995; 29: 89-95.
123. [123] Alberts B, Bray D, Lewis J et al. editors. Membrane transport of small molecules and the ionic basis of membrane excitability. In: The molecular biology of the cell, 3rd edn. New York: Garland Publishing, 1994: 518-519.
124. [124] Bircher NG. Acid-base physiology during advanced cardiac life support. Anesthesiol Clin North Am 1995; 13: 799-808.
125. [125] Eleff SM, Sugimoto H, Schaffner DH et al. Acidemia and brain pH during prolonged cardiopulmonary resuscitation in dogs. Stroke 1995; 26: 1028-1034.
126. [126] Bircher N, Safar P. Cerebral preservation during cardiopulmonary resuscitation. Crit Care Med 1985; 13: 185-190.
127. [127] Cummins RO, Graves JR. Clinical results of standard CPR: prehospital and inhospital. In: Kaye W, Bircher NG, editors. Cardiopulmonary resuscitation. New York: Churchill Livingstone, 1989: 87-102.
128. [128] Bircher NG. Physiology and pharmacology of standard cardiopulmonary resuscitation. In: Kaye W, Bircher NG, editors. Cardiopulmonary resuscitation. New York: Churchill Livingstone, 1989: 55-86.
129. [129] Edmonds-Seal J. Acid-base studies after cardiac arrest. A report of 64 cases. Acta Anaesthesiol Scand 1966; 23 (Suppl): 235-241.
130. [130] Redding JS, Pearson JW. Metabolic acidosis: a factor in cardiac resuscitation. South Med J 1967; 60: 926-932.
131. [131] Chazan JA, Stenson R, Kurland GS. The acidosis of cardiac arrest. N Engl J Med 1968; 278: 360-364.
132. [132] Henneman PL, Gruber JE, Marx JA. Development of acidosis in human beings during closed-chest and open-chest CPR. Ann Emerg Med 1988; 17: 672-675.
133. [133] Ornato JP, Gonzalez ER, Coyne MR et al. Arterial pH in out-of-hospital cardiac arrest: response time as a determinant of acidosis. Am J Emerg Med 1985; 3: 498-502.
134. [134] Ledingham IMCA, Norman JN. Acid-base studies in experimental cardiac arrest. Lancet 1962; ii: 967-969.
135. [135] Kette F, Weil MH, Gazmuri RJ. Buffer solutions may compromise cardiac resuscitation by reducing coronary perfusion pressure. JAMA 1991; 266: 2121-2126.
136. [136] Bircher NG. Cardiopulmonary cerebral resuscitation: brain resuscitation, mediators, glucose and anesthetics. Curr Opinion Anaesthesiol 1990; 3: 259-264.
137. [137] Marsh JD, Margolis TI, Kim D. Mechanisms of diminished contractile response to catecholamine during acidosis. Am J Physiol 1988; 254: H20-H27.
138. [138] Davies AG. Rapid desensitization and uncoupling of human β-adrenergic receptors in an in vitro model of lactic acidosis. J Clin Endocrinol Metab 1984; 59: 398-405.
139. [139] Falk JL, Rackow EC, Weil MH. End-tidal carbon dioxide concentration during cardiopulmonary resuscitation. N Engl J Med 1988; 318: 607-611.
140. [140] Haigney MCP, Lakatts EG, Stern MD et al. Sodium channel blockade reduces hypoxic sodium loading and sodium-dependent calcium loading. Circulation 1994; 90: 391-399.
141. + antiport. Circ Res 1989; 64: 676-685.
142. + exchange. Boca Raton, FL: CRC Press, 1988: 57-75.
143. [143] Kalimo H, Rehncrona S, Soderfeldt B et al. Brain lactic acidosis and ischemic cell damage: 2. Histopathology. J Cereb Blood Flow Metab 1981; 1: 313-327.
144. 2+ and pH. Biochem Biophys Res Commun 1992; 186: 782-789.
145. [145] Barry MA, Reynolds JE, Eastman A. Etoposide-induced apoptosis in human HL-60 cells is associated with intracellular acidification. Cancer Res 1993; 53: 2349-2357.
146. [146] Hurn PD, Koehler RC, Norris SE et al. Dependence of cerebral energy phosphate and evoked potential recovery on end-ischemic pH. Am J Physiol 1991; 290: H532-H541.
147. [147] Hurn PD, Koehler RC, Blizzard KK et al. Deferoxamine reduces early metabolic failure associated with severe cerebral ischemic acidosis in dogs. Stroke 1995; 26: 688-695.
148. [148] Plum F. What causes infarction in ischemic brain? Neurology 1983; 33: 222-233.
149. [149] Garcia JH, Liu KF, Ho KL. Neuronal necrosis after middle cerebral artery occlusion in Wistar rats progresses at different time intervals in caudoputamen and the cortex. Stroke 1995; 26: 636-643.
150. [150] Halvorsen L, Bay BK, Perron PR et al. Evaluation of an intraosseous infusion device for the resuscitation of hypovolemic shock. J Trauma 1990; 30: 652-659.
151. [151] Fiser DH. Intraosseous infusion. N Engl J Med 1990; 322: 1579-1581.
152. [152] Iserson KV. Intraosseous infusions in adults. J Emerg Med 1989; 7: 587-591.
153. [153] Jenkinson JP, Benedetto AR, Watson SC et al. Intraosseous small-volume fluid bolus injections enter central circulation during experimental cardiopulmonary resuscitation. Ann Emerg Med 1994; 23: A91 (abstract).
154. [154] Dubick MA, Pfeiffer JW, Clifford CB et al. Comparison of intraosseous and intravenous delivery of hypertonic saline/dextran in anesthetized, euvolemic pigs. Ann Emerg Med 1992; 21(5): 498-503.
155. [155] Spivey WH, Lathers CM, Malone DR et al. Comparison of intraosseous, central, and peripheral routes of sodium bicarbonate administration during CPR in pigs. Ann Emerg Med 1985; 14: 1135-1140.
156. [156] Orlowski J, Poremberg D, Gallagher J et al. Comparison study of intraosseous, central intravenous, and peripheral intravenous infusion of emergency drugs. AJDC 1990; 144: 112-117.
157. [157] Schneider SM, Yealy DM, Michaelson EA et al. Endotracheal versus intravenous epinephrine in the prehospital treatment of cardiac arrest. Orig Res 1990; 5: 341-348.
158. [158] Brown CG, Dzwonczyk R. Measurement of the approximate elapsed time of ventricular fibrillation and monitoring the response of the heart to therapy. US Patent No. 5,077,667, 1991.
159. [159] Strohmenger H-U, Lindner KH, Prengel AW et al. Effects of epinephrine and vasopressin on median fibrillation frequency and defibrillation success in a procine model of cardiopulmonary resuscitation. Resuscitation 1996; 31: 65-73.